0 Комментарии
0 Поделились
1Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Antiviral Drugs Market: Innovative Therapies Transforming Global HealthcareAntiviral Drugs Market: Advancing Global Healthcare Through Innovative Antiviral Therapies Antiviral Drugs Market Snapshot The Antiviral Drugs Market is witnessing stable growth as the global burden of viral infections continues to drive demand for effective therapeutic solutions. According to M2Square Consultancy, the global Antiviral Drugs Market was valued...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Global Cefalexin API Market to Reach USD 871 Million by 2034According to a new report from Intel Market Research, the global Cefalexin API market was valued at USD 571 million in 2024 and is projected to reach USD 871 million by 2034, growing at a robust CAGR of 6.4% during the forecast period (2025–2034). This growth is propelled by the increasing prevalence of bacterial infections, rising demand for generic antibiotics, and expanding...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
-
Global Molluscum Contagiosum Market to Reach USD 3.67 Billion by 2033, Growing at a 4.75% CAGRThe global molluscum contagiosum market size was valued at USD 2.42 billion in 2024 and is projected to reach from USD 2.53 billion in 2025 to USD 3.67 billion by 2033, growing at a CAGR of 4.75% during the forecast period (2025-2033). Market Scope and Research Methodology This report provides an in-depth analysis of the Molluscum Contagiosum...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Seasonal Influenza Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Seasonal Influenza Market CAGR Value The global seasonal influenza market size was valued at USD 13.47 billion in 2025 and is expected to reach USD 57.91 billion by 2033, at a CAGR of 20.00% during the forecast period Seasonal Influenza Market analysis report has studied key opportunities in...0 Комментарии 0 Поделились 740 Просмотры 0 предпросмотр
-
Sulbactam and Cefoperazone Market Growing at 7.7% CAGR Through 2034According to a new report from Intel Market Research, the global Sulbactam and Cefoperazone market was valued at USD 455 million in 2024 and is projected to reach USD 755 million by 2034, growing at a robust CAGR of 7.7% during the forecast period (2025–2034). This growth is propelled by the increasing prevalence of bacterial infections, rising antibiotic resistance, and growing demand...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр